Listen: The Need For Infosec To Accelerate The Adoption of Security Policies

 

With so many cyberattacks happening on a weekly basis, it often seems difficult to believe if we’ll ever get to a point of true safety online. Especially in the healthcare field, a lot of patient data is stored and often tried to be taken by hackers in exchange for ransom money. Specifically, when it comes to ransomware, healthcare organizations are constantly trying to find ways to invest in better security technology within their IT department budgets, however, preparedness and lack of informal training still haunts them. In fact, Healthcare IT News reports that only 41% of U.S. Healthcare workers indicate that they have received training on how to stay secure at work leaving plenty of room for hackers to do their magic. Sadly, only 14% of the overall U.S. Healthcare IT budget is geared towards security staffing. In order to get to a secure place in this industry, Healthcare Security workers are going to have to push for a digital renovation in the workplace or else the problem will never be solved.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More